This bill mandates that certain insurance policies in Nebraska provide coverage for the treatment of pediatric autoimmune neuropsychiatric disorders, specifically those associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome. It defines these conditions and outlines the required treatments, which may include antibiotics, medication, behavioral therapies, plasma exchange, and immunoglobulin, as recommended by a licensed healthcare provider. The bill applies to individual and group sickness and accident insurance policies, as well as self-funded employee benefit plans, unless preempted by federal law.

Additionally, the bill requires insurance policies to report coverage denial statistics related to these conditions to the Department of Insurance by October 1 each year, starting in 2027. The department is tasked with compiling this data into a report to be published on its website by December 1, 2028, and annually thereafter. The bill is designated as an emergency measure, taking effect immediately upon passage and approval.